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ABSTRACT
Patients with hemoglobin E disease usually have mild hemolytic anemia and mild splenomegaly. Acute 
infection including acute inflammatory disease of the liver caused by hepatitis A viral, which attacks patients 
with previous hemolytic anemia, may result in deterioration of anemia.
A 17-year-old female patient was admitted with chief complaint of having jaundiced body and non-specific 
prodromal symptoms within one week prior to admission. Physical examination revealed jaundiced skin and sclera 
as well as tenderness in right upper quadrant of the abdomen. Laboratory tests revealed microcytic hypochromic 
anemia with hemoglobin (Hb) level of 6.3 g/dL, increased reticulocyte count and abnormal morphology of 
erythrocyteson blood smear. Hemoglobin electrophoresis indicated hemoglobin E disease and serologic tests 
suggested a positive anti-HAV immunoglobulin M (IgM) with increased level of liver enzymes and functions. 
Abdominal ultrasound showed hepatosplenomegaly without extra-hepatic cholestasis. 
The working diagnosis was hepatitis A with intrahepatic cholestasis and hemoglobin E disease. The patient 
was treated with hepatoprotector and ursodeoxycholic acid. Anemia was not treated specifically. It was assumed 
that hemolytic anemia was worsened by acute infection of hepatitis A viral. The assumption had been proven to 
be right since there was improvement of anemia after the acute infection had recovered. Patients with hemoglobin 
E disease usually have mild anemia; however, in this case, the hemoglobin level decreased significantly due to 
the acute co-infection.
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ABSTRAK
Pasien dengan hemoglobinopati E pada umumnya menderita anemia hemolitik ringan dan splenomegali. 
Infeksi akut seperti infeksi hepatitis virus A, yang mengenai pasien dengan riwayat anemia hemolitik sebelumnya 
dapat memperburuk derajat anemia.
Seorang perempuan berusia 17 tahun datang dengan keluhan utama badan tampak kuning disertai gejala awal 
non spesifik sejak satu minggu sebelum masuk rumah sakit. Pemeriksaan fisik menunjukkan sklera dan kulit tampak 
pucat disertai nyeri tekan pada kuadran kanan atas abdomen. Pemeriksaan laboratorium menunjukkan anemia 
mikrositik hipokrom dengan kadar hemoglobin (Hb) 6,3 g/dL, retikulositosis dan kelainan morfologi eritrosit 
pada sediaan apus darah tepi. Hasil elektroforesis Hb memberikan kesan hemoglobinopati E. Tes serologis 
menunjukkan IgM anti-HAV positif dengan peningkatan fungsi dan enzim hati. Kesan hepatosplenomegali tanpa 
kolestasis ekstrahepatik didapatkan pada hasil ultrasonografi abdomen.
Diagnosis kerja pasien ini adalah hepatitis A disertai kolestasis intrahepatik dan hemoglobinopati E. 
Pasien diterapi dengan hepatoprotektor dan asam ursodeoksikolat, namun anemia tidak diobati secara spesifik. 
Perburukan anemia hemolitik yang terjadi diduga terjadi karena adanya infeksi hepatitis virus A yang menyertai. 
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Dugaan ini semakin kuat seiring dengan perbaikan anemia yang terjadi setelah infeksi akut teratasi. Anemia 
hemolitik pada pasien hemoglobinopati E biasanya ringan, namun pada kasus ini penurunan signifikan kadar 
Hb terjadi karena adanya infeksi akut yang menyertai.
Kata kunci: hemoglobinopati E, anemia, infeksi akut, hepatitis virus A
INTRODUCTION
Hemoglobin E disease is a congenital hemolytic 
anemia disorder, which includes structural abnormality 
of the hemoglobin caused by a mutation of beta 
chain of hemoglobin.1,2  To confirm the diagnosis, a 
blood test such as hemoglobin electrophoresis can 
be performed.3 Usually, hemoglobin E diseaseis 
manifested by the symptoms of mild thalassemia, 
which appears as mild microcytic hypochromic 
anemia.2 In several cases, anemia occurs more 
prominently, particularly when there is simultaneous 
acute co-infection.4 Moreover, anemia in acute 
infections may occur due to several factors including 
previous medical condition. The severity of 
anemia depends on patient’s medical condition. 
Patients who have previous underlying disease 
will have more severe anemia than patients who 
do not have previous illness.5 Anemia also occurs 
as hematologic complication of hepatitis A viral 
infection. In patients with hemoglobin E disease 
and hepatitis A viral infection, the hemoglobin 
level will significantly decrease.6 Hepatitis A virus 
commonly causes severe cholestasis syndrome 
with abnormal clinical, laboratory and histology 
findings.7 The laboratory findings include increased 
alkali phosphatase and gamma glutamiltransferase 
serum level, increased bilirubin serum level, 
reduced prothrombin time and minimal increase 
of aminotransferase serum level. Clinical findings 
may include pruritus, malaise, xanthoma, steathorea, 
which usually can be found in patients with fat-
soluble vitamin deficiency. Histological findings of 
bilirubin obstruction (bilirubinostasis), hepatocyte 
degeneration (cholestasis), small biliary duct 
destruction, pericholangitis, portal edema and 
biliary cirrhosis can also be found.8,9 Cholestasis 
due to hepatitis A viral infection is almost certainly 
intrahepatic with pruritus as the main symptom.7
Hepatitis A with cholestasis is treated by total bed 
rest, diet and nutrition for liver disease in accordance 
with the clinical condition, as well as symptomatic 
and adjuvant therapy.6 To relieve the cholestasis, 
ursodeoxycholic acid is used. Previous studies 
indicated that administration of ursodeoxycholic 
acid regimen may cause significant reduction of liver 
enzymes and bilirubin serum level and improves the 
generalized pruritus symptom.7,10
Hemoglobin E disease belongs to minor thalassemia.3 
The management of hemoglobin E disease is similar to 
management of minor thalassemia itself.6 Anemia that 
occurs in hemoglobin E disease is treated as in general 
cases.10 But if the anemia is prominent, packed red cells 
(PRC) transfusion is frequently needed.5 It is important 
to notice whether the recovery of acute infection is 
followed by improved hemoglobin level. If the anemia 
does not improved, further investigation to confirm the 
etiology of anemia should be carried out.3,11
CASE ILLUSTRATION
A 17-year-old female patient was admitted with 
chief complaint of having jaundiced body since one 
day prior to the admission. She had one-week history 
of fever, headache, myalgia, loss of appetite, nausea 
and vomiting before the admission. She also reported 
dark urine since 3 days prior to admission. The patient 
lived in a dormitory with low hygiene standard, which 
was overcapacity for students housing and the dining 
room was located near the bathroom. Her physical 
examination revealed signs of anemia, as well as 
jaundice, mild splenomegaly, mild hepatomegaly and 
abdominal tenderness in the right upper quadrant. She 
also had poor nutritional state with body mass index 
of 18.1 kg/m2.
Laboratory results on admission showed a condition 
of hypochromic microcytic anemia with hemoglobin 
level 6.3 g/dL, hematocrit 26%, low mean corpuscular 
volume (MCV), mean corpuscular hemoglobin 
(MCH), mean corpuscular hemoglobin volume 
(MCHC) level, and high reticulocytes count (4.2%). 
The immunoserological findings demonstrated 
anti-HAV IgM level of 2.73 IU/mL with aspartate 
transaminase (AST) activity level of 791 U/L and 
alanine aminotransferase (ALT) level of 837 U/L, 
direct bilirubin level of 8.37 mg/dL, indirect bilirubin 
level of 4.57 mg/dL, total bilirubin level of 12.94 mg/
dL, phosphatase alkali level of 260 U/L, and gamma 
glutamyltransferase activity level of 72 U/L. 
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The working diagnosis on admission was hepatitis 
A and hemolytic anemia. A significant decreased 
level of hemoglobin and splenomegaly had directed 
the diagnosis to thalassemia. The next laboratory 
results showed normal serum iron level, normal 
ferritin level and the total iron binding capacity 
(TIBC) was also normal. A blood smear indicated 
hypochromic microcytic anemia with existence of 
target cells, spherocytes, and teardrop cells. However, 
the hemoglobin electrophoresis suggested hemoglobin 
E disease. The abdominal ultrasound showed mild 
hepatosplenomegaly without dilatation of biliary tree 
(Figure 1).The patient was advised to have a total 
bed rest. She was given metoclopramide tablet 10 
mg thrice daily orally to relieve nausea and vomiting. 
Ursodeoxycholic acid tablet 500 mg twice daily was 
administrated to reduce the cholestatic symptoms. 
Hepatoprotector was given to improve the elevated 
liver enzymes. The anemia was only being observed 
without any specific medication.
level were AST of 23 U/L and ALT of 14 U/L. She was 
discharged from the hospital with final diagnosis of 
hepatitis A with cholestasis and hemoglobin E disease. 
After one month, there was improved hemoglobin level 
from a baseline level of 6.3 to 8.1 g/dL.
DISCUSSION
The diagnosis of cholestatic hepatitis A was 
established based on clinical findings of acute viral 
hepatitis, including non-specific prodromal findings 
and gastrointestinal symptoms (malaise, anorexia, 
nausea and vomiting), flu-like syndromes (headache 
and myalgia), acute sudden onset symptoms, fever.
The prodromal symptoms ceased when the jaundice 
appeared, but other symptoms like anorexia, malaise, 
and fatigue persisted. The dark urine was followed 
by jaundiced skin.6,8,9 Physical examination showed 
mild hepatosplenomegaly with abdominal tenderness 
in the right upper quadrant. Severe jaundice persisted 
before the complete recovery and it may due to 
cholestasis.9 However, the specific symptom for 
intrahepatic cholestasis such as pruritus was not found. 
The absence of pruritus may indicate that there was 
only mild increase of bilirubin level.8,9 The positive 
immunoserological finding of anti-HAV IgM test has 
supported the diagnosis of acute hepatitis A. Increased 
serum level of direct, indirect, and total bilirubin as 
well as AST and ALT activity level less than 500U/L, 
elevated alkaline phosphatase of more than four folds 
have also supported the diagnosis of cholestatic type 
of hepatitis.9 The abdominal ultrasound did not show 
any dilatation of biliary tree, which may indicate 
intrahepatic cholestasis.8,9 However, identifying the 
etiology of hepatitis may help physicians to rule out 
the cholestatic type since the pathology of cholestasis 
due to hepatitis A viral infection must be intrahepatic 
type.6,8,9
The diagnosis of hemoglobin E disease was 
established based on clinical findings such as mild 
hepatomegaly, laboratory results that indicated 
hemolytic anemia (increased of reticulocytes count), 
blood smear test showed hypochromic microcytic 
anemia, target cells, spherocytes and the hemoglobin 
electrophoresis suggested hemoglobin E disease.2,3 This 
case is special since usually patients with hemoglobin E 
disease have mild anemia with hemoglobin level about 
10–13 g/dL, but in this case, her hemoglobin level was 
significantly reduced (6.3 g/dL).2,3,6
The cholestatic hepatitis A was treated according to 
the common standards.7 The patient was hospitalized 
because of her severe gastrointestinal symptoms. To 
Figure 1. The abdominal ultrasound showed mild 
hepatosplenomegaly without dilatation of biliary tree 
On the third day of hospitalization, her gastrointestinal 
symptoms were improved. Laboratory results showed 
reduced direct bilirubin level of 5.48 mg/dL, indirect 
bilirubin level of 1.98 mg/dL, total bilirubin level 
of 7.46 mg/dL. The liver enzyme levels were 
also significantly reduced including aspartate 
transaminase (AST) activity level of 150 U/L and 
alanine aminotransferase (ALT) activity level of 203 
U/L. After being hospitalized for a week, the patient 
was clinically improved and her laboratory results were 
getting better. The direct bilirubin was 0.79 mg/dL and 
total bilirubin was 1.48 mg/dL. The liver enzymes 
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reduce the cholestatic symptoms, the patient was given 
ursodeoxycholic acid since it has a good efficacy in 
improving bilirubin level in patients with cholestasis.7,10 
The patient was also given hepatoprotector as adjuvant 
therapy to improve her bilirubin and liver enzymes 
level. The combination of ursodeoxycholic acid and the 
hepatoprotector showed a better efficacy in improving 
bilirubin and liver enzymes level.6,7,10
The hemolytic anemia in this patient may not 
require any specific treatment. It is assumed that the 
deterioration of anemia in this patient was due to 
hepatitis A viral infection as the acute co-infection since 
the patient has suffered from hemoglobin E disease, 
the underlying disease.4,5 The improvement of anemia, 
i.e. increasedhemoglobin level from 6.3 g/dL to 8.1 g/
dL after the hepatitis A infection has been recovered in 
one month observation has supported the hypotheses.5
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